Pharma channel feed

Five ques­tions on the fu­ture of Lil­ly’s Alzheimer’s drug, from Dunn’s lega­cy to ARIA

Last year

Phar­ma bris­tles at Biden’s call to ex­pand IRA ne­go­ti­a­tions at State of the Union

Last year
FDA+

BeiGene files patent suits against San­doz, MSN Group

Last year
Law

J&J opens SXSW as health spon­sor

Last year
Marketing

Akero ex­ec­u­tives point to ad­vanced fi­bro­sis pa­tients for MASH drug

Last year
R&D

Up­dat­ed: FDA ap­proves weight loss drug We­govy to re­duce car­dio­vas­cu­lar events

Last year
FDA+

Gilead­'s on­col­o­gy cam­paign spot­lights metasta­t­ic breast can­cer pa­tients who of­ten feel un­seen

Last year
Marketing

Up­dat­ed: Phar­ma com­pa­nies present IRA cas­es in New Jer­sey court

Last year
Law

Law­mak­ers call for 'line in the sand' be­tween US and Chi­nese biotech com­pa­nies

Last year
China
Law

BeiGene’s Brukin­sa bags fifth FDA ap­proval, like­ly po­si­tion­ing it for con­tin­ued sales growth

Last year
FDA+

Lil­ly push­es back on the pop cul­ture clam­or for obe­si­ty drugs in new TV ads

Last year
Marketing

Boehringer In­gel­heim caps in­haler out-of-pock­et costs at $35 af­ter po­lit­i­cal pres­sure

Last year

Bris­tol My­ers nabs ap­proval for Op­di­vo com­bo as first-line blad­der can­cer treat­ment

Last year
R&D
FDA+

No­vo touts ear­ly da­ta for next-gen oral weight loss drug as it out­lines next steps

Last year
R&D

Drug­mak­ers gear up for joint IRA ar­gu­ments as PhRMA ap­peals Texas ver­dict

Last year
Law

Sun Phar­ma re-en­lists pop­u­lar ‘Pim­ple Pop­per’ doc­tor for ac­ne brand TV cam­paign

Last year
Marketing

FDA sees suc­cess in mod­el-in­formed drug de­vel­op­ment pi­lot

Last year
FDA+

Tar­sus’ eye drops in­ter­rupt an an­i­mat­ed mite 'par­ty’ in first DTC ad for Xdemvy

Last year
Marketing

Val­isure pres­sures FDA to re­call ac­ne treat­ments af­ter find­ing car­cino­gen

Last year
FDA+

FDA faces flat­lined bud­get as clock ticks for Con­gress to pass gov­ern­ment fund­ing

Last year
FDA+

Sen­ate com­mit­tee ad­vances bill tar­get­ing Chi­nese man­u­fac­tur­ers as BIO faces at­tack for back­ing WuXi

Last year
China
Manufacturing

Sen. War­ren at­tacks GSK's de­ci­sion to shift in­haler from brand to au­tho­rized gener­ic

Last year
Law

Eu­ro­pean Com­mis­sion spells out new pro­pos­als for health tech­nol­o­gy as­sess­ments

Last year
FDA+

Pfiz­er says IRA im­pact will be 'mod­est,' maps out R&D pri­or­i­ty changes

Last year
First page Previous page 66676869707172 Next page Last page
A service from the Financial Times